4.6 Review

Lactate Dehydrogenase Inhibition: Biochemical Relevance and Therapeutical Potential

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 26, Issue 18, Pages 3242-3252

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867324666170209103444

Keywords

Lactate dehydrogenase; enzyme inhibitors; quinoline derivatives; oxamate and derivatives; galloflavin; bifunctional inhibitors; miRNA and shRNAs

Ask authors/readers for more resources

Lactate dehydrogenase (LHD) is a key enzyme of anaerobic metabolism in almost all living organisms and it is also a functional checkpoint for glucose restoration during gluconeogenesis and single-stranded DNA metabolism. This enzyme has a well preserved structure during evolution and among the species, with little, but sometimes very useful, changes in the amino acid sequence, which makes it an attractive target for the design and construction of functional molecules able to modulate its catalytic potential and expression. Research has focused mainly on the selection of modulator especially as far as LDH isozymes (especially LDH-5) and lactate dehydrogenases of Plasmodium falciparum (pfLDH) are concerned. This review summarizes the recent advances in the design and development of inhibitors, pointing out their specificity and therapeutic potentials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available